Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE
NCT07318259
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL:
BCMA/CD70 CAR-T cells
Sponsor
Chongqing Precision Biotech Co., Ltd